Naoto Sasaki
Kobe Pharmaceutical University(JP)
Publications by Year
Research Areas
Atherosclerosis and Cardiovascular Diseases, T-cell and B-cell Immunology, Chemokine receptors and signaling, Aortic aneurysm repair treatments, Adipokines, Inflammation, and Metabolic Diseases
Most-Cited Works
- → Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis(2018)606 cited
- → Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease(2016)308 cited
- → Oral Administration of an Active Form of Vitamin D 3 (Calcitriol) Decreases Atherosclerosis in Mice by Inducing Regulatory T Cells and Immature Dendritic Cells With Tolerogenic Functions(2010)197 cited
- → Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease(2016)172 cited
- → Oral Anti-CD3 Antibody Treatment Induces Regulatory T Cells and Inhibits the Development of Atherosclerosis in Mice(2009)171 cited
- → Gut Microbiome and Plasma Microbiome-Related Metabolites in Patients With Decompensated and Compensated Heart Failure(2018)129 cited
- → Overexpression of Cytotoxic T-Lymphocyte–Associated Antigen-4 Prevents Atherosclerosis in Mice(2016)111 cited
- → Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis(2017)111 cited
- → Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice(2005)109 cited
- → Endothelial progeria induces adipose tissue senescence and impairs insulin sensitivity through senescence associated secretory phenotype(2020)104 cited